NANO-X IMAGING LTD (NNOX)
IL0011681371 - Common Stock
Taking everything into account, NNOX scores 3 out of 10 in our fundamental rating. NNOX was compared to 110 industry peers in the Health Care Providers & Services industry. NNOX has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, NNOX is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
NNOX had negative earnings in the past year.
NNOX had a negative operating cash flow in the past year.
NNOX had negative earnings in each of the past 5 years.
NNOX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
NNOX has a Return On Assets of -29.36%. This is amonst the worse of the industry: NNOX underperforms 81.82% of its industry peers.
NNOX has a worse Return On Equity (-32.81%) than 65.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.36% | ||
| ROE | -32.81% | ||
| ROIC | N/A |
ROA(3y)-29.8%
ROA(5y)-59.51%
ROE(3y)-34.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for NNOX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
NNOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NNOX has been increased compared to 1 year ago.
The number of shares outstanding for NNOX has been increased compared to 5 years ago.
NNOX has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 8.11 indicates that NNOX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 8.11, NNOX belongs to the best of the industry, outperforming 93.64% of the companies in the same industry.
There is no outstanding debt for NNOX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 8.11 |
ROIC/WACCN/A
WACC9.51%
2.3 Liquidity
NNOX has a Current Ratio of 5.16. This indicates that NNOX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.16, NNOX belongs to the best of the industry, outperforming 94.55% of the companies in the same industry.
NNOX has a Quick Ratio of 5.09. This indicates that NNOX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of NNOX (5.09) is better than 94.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.16 | ||
| Quick Ratio | 5.09 |
3. Growth
3.1 Past
NNOX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.00%, which is quite impressive.
Looking at the last year, NNOX shows a quite strong growth in Revenue. The Revenue has grown by 15.44% in the last year.
EPS 1Y (TTM)56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.46%
Revenue 1Y (TTM)15.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%22.27%
3.2 Future
NNOX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.95% yearly.
The Revenue is expected to grow by 70.68% on average over the next years. This is a very strong growth
EPS Next Y16.11%
EPS Next 2Y24.07%
EPS Next 3Y28.54%
EPS Next 5Y18.95%
Revenue Next Year25.31%
Revenue Next 2Y105.24%
Revenue Next 3Y126.28%
Revenue Next 5Y70.68%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for NNOX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NNOX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
NNOX's earnings are expected to grow with 28.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.07%
EPS Next 3Y28.54%
5. Dividend
5.1 Amount
NNOX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NANO-X IMAGING LTD
NASDAQ:NNOX (12/2/2024, 8:00:01 PM)
Premarket: 6.46 -0.06 (-0.92%)6.52
+0.06 (+0.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap381.42M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.36% | ||
| ROE | -32.81% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.16 | ||
| Quick Ratio | 5.09 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)56%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y16.11%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.44%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y